Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

ROBERT LEWIS IKEMAN

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1407831498
CMS profile
17882
Location
SARASOTA, FL

General Payments · PY2019–2025

$17,444.05

  • Reported across 827 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$809.84

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $809.84 35

By paying entity

PY2025 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $249.31 8
NOVARTIS PHARMACEUTICALS CORPORATION $103.61 6
Acerta Pharma LLC $93.35 5
GlaxoSmithKline, LLC. $92.90 5
Amgen Inc. $84.95 4
UCB, Inc. $56.31 1
Genentech USA, Inc. $56.10 3
Lilly USA, LLC $43.41 2
Mallinckrodt Hospital Products Inc. $29.90 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $4,206.73 227
PY2020 $2,143.78 120
PY2021 $1,873.48 91
PY2022 $2,382.82 100
PY2023 $3,270.45 134
PY2024 $2,756.95 120
PY2025 $809.84 35

Payment records · PY2025 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2025 201920202021202220232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $22.10 01/21/2025 Food and Beverage Undisputed 06/30/2026 1202091742 CMS
ABBVIE INC. $18.18 02/03/2025 Food and Beverage Undisputed 06/30/2026 1202091744 CMS
ABBVIE INC. $125.00 02/19/2025 Food and Beverage Undisputed 06/30/2026 1202091746 CMS
ABBVIE INC. $29.07 03/17/2025 Food and Beverage Undisputed 06/30/2026 1202091748 CMS
ABBVIE INC. $23.37 04/30/2025 Food and Beverage Undisputed 06/30/2026 1202091750 CMS
ABBVIE INC. $8.03 05/07/2025 Food and Beverage Undisputed 06/30/2026 1202091752 CMS
ABBVIE INC. $1.18 05/13/2025 Food and Beverage Undisputed 06/30/2026 1202091754 CMS
ABBVIE INC. $22.38 05/13/2025 Food and Beverage Undisputed 06/30/2026 1202091756 CMS
Amgen Inc. $27.33 01/14/2025 Food and Beverage Undisputed 06/30/2026 1228377318 CMS
Amgen Inc. $26.26 01/14/2025 Food and Beverage Undisputed 06/30/2026 1228377322 CMS
Amgen Inc. $15.49 04/01/2025 Food and Beverage Undisputed 06/30/2026 1228377320 CMS
Amgen Inc. $15.87 04/07/2025 Food and Beverage Undisputed 06/30/2026 1228377316 CMS
AstraZeneca Pharmaceuticals LP $22.76 01/16/2025 Food and Beverage Undisputed 06/30/2026 1206647813 CMS
AstraZeneca Pharmaceuticals LP $14.14 02/04/2025 Food and Beverage Undisputed 06/30/2026 1207272764 CMS
AstraZeneca Pharmaceuticals LP $17.84 02/12/2025 Food and Beverage Undisputed 06/30/2026 1206537556 CMS
AstraZeneca Pharmaceuticals LP $21.97 03/13/2025 Food and Beverage Undisputed 06/30/2026 1206507667 CMS
AstraZeneca Pharmaceuticals LP $16.64 05/14/2025 Food and Beverage Undisputed 06/30/2026 1206284194 CMS
Genentech USA, Inc. $17.46 02/25/2025 Food and Beverage Undisputed 06/30/2026 1211577270 CMS
Genentech USA, Inc. $21.43 04/29/2025 Food and Beverage Undisputed 06/30/2026 1211577273 CMS
Genentech USA, Inc. $17.21 05/20/2025 Food and Beverage Undisputed 06/30/2026 1211577277 CMS
GlaxoSmithKline, LLC. $18.57 01/29/2025 Food and Beverage Undisputed 06/30/2026 1190972197 CMS
GlaxoSmithKline, LLC. $20.00 02/17/2025 Food and Beverage Undisputed 06/30/2026 1190692308 CMS
GlaxoSmithKline, LLC. $18.61 03/19/2025 Food and Beverage Undisputed 06/30/2026 1190683531 CMS
GlaxoSmithKline, LLC. $21.61 04/08/2025 Food and Beverage Undisputed 06/30/2026 1190732318 CMS
GlaxoSmithKline, LLC. $14.11 05/12/2025 Food and Beverage Undisputed 06/30/2026 1190546998 CMS
Lilly USA, LLC $17.07 01/07/2025 Food and Beverage Undisputed 06/30/2026 1186902758 CMS
Lilly USA, LLC $26.34 02/11/2025 Food and Beverage Undisputed 06/30/2026 1186877379 CMS
Mallinckrodt Hospital Products Inc. $29.90 05/21/2025 Food and Beverage Undisputed 06/30/2026 1211971774 CMS
Novartis Pharmaceuticals Corporation $19.88 01/28/2025 Food and Beverage Undisputed 06/30/2026 1200323549 CMS
Novartis Pharmaceuticals Corporation $20.61 02/10/2025 Food and Beverage Undisputed 06/30/2026 1200323551 CMS
Novartis Pharmaceuticals Corporation $20.11 02/25/2025 Food and Beverage Undisputed 06/30/2026 1200323557 CMS
Novartis Pharmaceuticals Corporation $14.02 03/11/2025 Food and Beverage Undisputed 06/30/2026 1200323555 CMS
Novartis Pharmaceuticals Corporation $15.11 03/25/2025 Food and Beverage Undisputed 06/30/2026 1200323559 CMS
Novartis Pharmaceuticals Corporation $13.88 04/22/2025 Food and Beverage Undisputed 06/30/2026 1200323561 CMS
UCB, Inc. $56.31 03/18/2025 Food and Beverage Undisputed 06/30/2026 1224573109 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.